Xeltis wants to make life better for patients who need blood vessel or heart valve replacement. At Xeltis, we are leveraging breakthrough science to transform cardiovascular therapy – making the seemingly impossible happen.
We enable the patient’s own body to naturally restore a new blood vessel or heart valve through a therapeutic approach called Endogenous Tissue Restoration (ETR). We aim to overcome the limitations of current options: to improve the lives of millions of patients requiring blood vessel or heart valve replacement, while reducing overall healthcare systems costs.
We are striving to bring our restorative approach in cardiovascular therapy to clinicians and patients around the world. We are truly motivated by helping patients who need a new blood vessel or heart valve to live a better life, soon.
Find out more or adjust your settings.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.